trifluoperazine has been researched along with Cataract in 2 studies
Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| MARGOLIS, LH | 1 |
| GOBLE, JL | 1 |
| Sanderson, J | 1 |
| Gandolfi, SA | 1 |
| Duncan, G | 1 |
2 other studies available for trifluoperazine and Cataract
| Article | Year |
|---|---|
LENTICULAR OPACITIES WITH PROLONGED PHENOTHIAZINE THERAPY: A POTENTIAL HAZARD WITH ALL PHENOTHIAZINE DERIVATIVES.
Topics: Antipsychotic Agents; Cataract; Chlorpromazine; Drug Therapy; Fluphenazine; Phenothiazines; Prochlor | 1965 |
Calmodulin antagonists induce changes in lens permeability and transparency.
Topics: Animals; Calcium; Calmodulin; Cataract; Cell Membrane Permeability; Imidazoles; Lens, Crystalline; M | 1994 |